AKEBIA THERAPEUTICS, INC. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
AKEBIA THERAPEUTICS, INC. (AKBA) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $6.75 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2014-08-11
- AKEBIA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2014-06-30 was $1.25M.
- AKEBIA THERAPEUTICS, INC. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2014-03-31 was $5.50M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 85 month |
|---|---|---|---|
| 2014-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $6.75M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $5.50M 10-Q · filed 2014-05-12 | $18.68M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |